Main Uses of Nicardipine

Nicardipine is a calcium channel blocker primarily utilized for the management of cardiovascular conditions related to high blood pressure and vascular resistance. It works by relaxing the muscles of the heart and blood vessels, which facilitates easier blood flow and reduces the workload on the cardiovascular system.

Chronic Stable Angina

Nicardipine is indicated for the management of chronic stable angina. By dilating the coronary arteries, it increases the oxygen supply to the heart muscle. This helps to reduce the frequency and severity of chest pain episodes during physical exertion or stress, improving the patient's capacity for daily activities.

Hypertension Management

One of the primary applications of nicardipine is the treatment of hypertension (high blood pressure). It may be used alone or in combination with other antihypertensive medications to help maintain blood pressure within a target range. Effective management of blood pressure is a key factor in reducing the long-term risk of cardiovascular complications.

Benefits of Treatment

Cardiovascular Protection

By maintaining lower blood pressure levels, nicardipine helps to mitigate the long-term strain on the heart and arteries. This systemic reduction in pressure is associated with a decreased risk of serious events such as strokes and myocardial infarctions (heart attacks).

Improved Vascular Flow

As a vasodilator, nicardipine reduces peripheral vascular resistance. This means the heart does not have to pump as hard to circulate blood throughout the body. For patients with angina, this improved efficiency helps balance the heart's oxygen demand with its available supply.

Regulatory References

1. Nicardipine: MedlinePlus Drug Information

Eligibility Profile for Nicardipine

This information is based strictly on authoritative government regulatory documents, outlining the official limitations and restrictions for the use of nicardipine.

---

Populations that Must Not Use Nicardipine (Contraindications)

Condition / Population	Status
Known Hypersensitivity to nicardipine or excipients	Contraindicated
Advanced Aortic Stenosis	Contraindicated
Unstable Angina (IV formulation)	Contraindicated
Immediately following Myocardial Infarction (IV formulation)	Contraindicated

---

Populations Requiring Restricted or Conditional Use

Condition / Population	Restriction
Impaired Hepatic or Renal Function	Use with caution; dosage adjustment and close monitoring are required.
Heart Failure	Use with caution and titrate slowly due to potential worsening of cardiac insufficiency.
Pregnancy	Use is conditional; only if the potential benefit justifies the risk, and only for specific indications like severe pre-eclampsia (EMA).
Breastfeeding	Not recommended as the drug is excreted into breast milk.
Pediatric Population (under 18 years)	Safety and efficacy not established; use only for life-threatening hypertension in specialist settings.

---

Note on Eligibility: Nicardipine is generally reserved for adult patients who do not present with any formal contraindications. Official regulatory documents define eligibility by excluding patients with specific severe cardiac conditions and requiring heightened caution, dose adjustments, and monitoring for those with significant organ impairment.

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Nicardipine based on regulatory prescribing information.

Pharmacokinetic Interactions

Nicardipine is primarily metabolized through the CYP3A4 enzyme system and is also documented to inhibit multiple cytochrome P450 enzymes, including CYP3A4, CYP2C8, CYP2C9, and CYP2D6. This forms the basis for numerous exposure-altering interactions.

Interacting Agent Category	Official Interaction Outcome
Strong CYP3A4 Inhibitors (e.g., Ketoconazole)	Increases Nicardipine plasma concentration, leading to enhanced effects.
CYP3A4 Inducers (e.g., Rifampicin, Phenytoin)	Decreases Nicardipine plasma concentration, potentially reducing efficacy.
Immunosuppressants (e.g., Cyclosporine, Tacrolimus)	Nicardipine increases the plasma levels of these co-administered drugs.
Cimetidine	Significantly increases oral Nicardipine plasma levels.

Pharmacodynamic and Contraindicated Interactions

Dantrolene co-administration is strictly contraindicated due to the formally documented risk of severe cardiovascular collapse. A pharmacodynamic interaction is documented with Beta-blockers and Inhalational Anesthetics, carrying a formal risk of additive hypotensive effects. Caution is also noted with Magnesium Sulfate due to the possible risk of excessive blood pressure decrease.

Food and Substance Interactions

Grapefruit Juice is documented to significantly increase the oral bioavailability and plasma levels of Nicardipine. Alcohol (Ethanol) may result in documented additive effects in lowering blood pressure. The interaction profile highlights that patients with impaired hepatic or renal function may experience altered systemic clearance, influencing the severity of these documented interactions.

Nicardipine exerts its action by functioning as an antagonist that selectively blocks the L-type Voltage-Gated Calcium Channels (Cav1.2) found primarily on the muscle cells of the arteries. This molecular interaction prevents the essential influx of extracellular calcium ions (Ca^2+) required for the muscle to contract, which is the initial step of the mechanism.

By inhibiting the calcium-dependent activation of the enzyme myosin light-chain kinase, the drug triggers the widespread relaxation of arterial smooth muscle (vasodilation). This systemic opening of the blood vessels leads directly to a reduction in systemic vascular resistance (SVR), which consequently decreases the mechanical resistance (afterload) exerted on the heart.

The drug's mechanism engages the body's physiological regulatory feedback loops: the rapid fall in pressure triggers the baroreceptor reflex. This physiological feedback increases sympathetic activity, resulting in a compensatory rise in heart rate, known as reflex tachycardia.

How Nicarpine is Used: Administration Guidelines

Nicardipine is administered through two approved routes: oral for chronic, outpatient management and intravenous (IV) infusion for short-term, acute care requiring continuous supervision.

---

Administration and Dosing

Route / Form	Standard Adult Dosing Regimen	Frequency and Key Instruction
Oral Conventional Capsules (20 mg, 30 mg)	Starting dose: 20 mg. Maintenance range: 20 to 40 mg.	Taken three times daily (TID). Dosage adjustments should occur no more frequently than 3-day intervals.
Oral Extended-Release Capsules (30 mg, 45 mg, 60 mg)	Starting dose: 30 mg. Maintenance range: 30 to 60 mg.	Taken twice daily (BID).
Intravenous (IV) Infusion (e.g., 2.5 mg/mL concentrate)	Initial rate: 5 mg/hour. Maximum rate: 15 mg/hour.	Administered via continuous infusion with a control pump; dose adjustments are made in small increments every 5 to 15 minutes.

---

Administration Requirements and Special Populations

IV Preparation: The Nicardipine concentrate must be diluted prior to infusion to a specified concentration (e.g., 0.1 mg/mL). The solution must be administered via a large peripheral vein or central line and should not be mixed with any other products in the same line.

Oral Transition: For patients transitioning from IV to oral therapy, the first oral dose is typically given 1 hour prior to the discontinuation of the IV infusion.

Dose Adjustment: Lower starting doses are indicated for patients with hepatic or renal impairment due to altered drug clearance, and caution is used when titrating the dose in older adults.

Nicarpine is a dihydropyridine calcium channel blocker studied for its effects in managing high blood pressure (hypertension) and chest pain associated with reduced blood flow to the heart (chronic stable angina).

Clinical Findings in Hypertension

Research has explored Nicarpine's use in mild to moderate hypertension, both as a standalone treatment and in combination with other blood pressure medications.

• Studies have shown that in patients with hypertension, the use of Nicarpine was associated with a reduction in both systolic and diastolic blood pressure measurements.
• The blood pressure–lowering effect typically occurs within minutes of intravenous administration, with an offset of action following discontinuation.

Research on Angina Pectoris

Clinical trials have investigated Nicarpine's role in chronic stable angina. The research evaluated the drug's effect on exercise tolerance and the time taken until the onset of chest pain.

• In trials comparing Nicarpine to placebo, participants receiving Nicarpine showed improvement in measures of exercise capacity.
• Comparative studies have explored whether Nicarpine's effects differ from those of other calcium channel blockers or beta-blockers in patients with stable angina.

Specific Safety Considerations in Studies

The safety profile has been assessed across numerous clinical trials. Side effects often observed in studies were generally related to the drug's blood vessel relaxing properties, such as headache, flushing, and peripheral edema (swelling of the ankles or legs). These effects were usually minor and transient.

Common questions about Nicarpine (FAQ)

---

Q: Are there any foods or drinks that should be avoided when taking Nicarpine?

According to the official product information, Grapefruit Juice is documented to increase the amount of Nicarpine in the bloodstream. Additionally, Alcohol (Ethanol) may result in documented additive effects that further lower blood pressure. These interactions are described in the official product information.

Q: What are the signs of a serious allergic reaction to Nicarpine?

Regulatory documents list that a known hypersensitivity (severe allergy) to Nicarpine is a formal contraindication. Signs of a serious allergic reaction may include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. A known hypersensitivity to the drug is listed as a contraindication in the official product documents.

Q: Do I need a prescription to get Nicarpine?

Yes, Nicarpine is officially classified as a prescription-only drug. It is available only with a prescription from a licensed healthcare provider.

Q: Does Nicarpine cause weight gain or loss?

Official documents do not list weight gain or weight loss as a direct common adverse reaction. However, a common side effect is peripheral edema (swelling or fluid retention in the ankles or legs), which is an accumulation of fluid.

Q: Can Nicarpine be used by people who have diabetes?

Regulatory documents do not list diabetes mellitus as a formal contraindication or a special patient population requiring specific dose adjustment, unlike those with liver or kidney impairment. However, official information notes possible interactions with antidiabetic drugs.

Q: Does Nicarpine affect sleep?

Official regulatory documents have noted effects on the Central Nervous System. Documented adverse reactions include both drowsiness and insomnia (difficulty sleeping).

Q: How long does Nicarpine stay in your system after stopping it?

Pharmacokinetic data from the official labeling indicates that the drug has an elimination half-life of approximately 8.6 hours. This means it generally takes about 48 hours for over 90% of the administered dose to be eliminated from the body.

Q: Are there any common interactions with over-the-counter pain relievers?

Regulatory interaction data notes possible interactions with certain non-prescription pain relievers, such as NSAIDs and acetaminophen. Regulatory information indicates that these combined effects could potentially affect blood pressure.

Q: Does Nicarpine interact with herbal supplements?

Official advice indicates that the use of herbal supplements and all non-prescription products may affect the action of the drug. This information is based on the general caution against co-administering other substances.

Q: Are there restrictions on driving while taking Nicarpine?

Regulatory documents list side effects such as dizziness and drowsiness as common effects of the drug. These side effects may affect a patient’s ability to drive or operate complex machinery.

Q: Why does Nicarpine need to be taken consistently?

The drug is characterized by a relatively short half-life. This property requires frequent administration (two to three times daily) to maintain the stable blood levels required for the drug to work as intended.

Q: Is Nicarpine a newer or older medication?

According to the Highlights of Prescribing Information, the drug received its initial U.S. approval in 1988.

Q: Can Nicarpine affect the results of lab tests?

Regulatory documents note that the drug can be associated with abnormal hepatic function. This refers to elevations in liver enzymes, which may be reflected in routine laboratory test results.

Q: What happens if I accidentally take two doses of Nicarpine?

Official information on overdosage indicates that taking too much Nicarpine may lead to documented symptoms. These symptoms can include marked hypotension (very low blood pressure), a slow heart rate (bradycardia), flushing, and drowsiness.

Q: Is Nicarpine safe to take with common vitamins?

Official advice indicates that the use of vitamins may affect the intended action of the Nicarpine. This information is based on the general caution against co-administering other substances.

Nicardipine storage and disposal are governed by official regulatory requirements to maintain product stability and safety.

Storage Conditions

Both oral capsules and the intravenous (IV) solution must be stored at Controlled Room Temperature, defined as 20 C to 25 C. The medication must be protected from light and kept in its original container until use. Oral capsules should be stored away from excess heat and moisture, and the IV solution should not be stored above 25 C.

Stability and Disposal

The diluted IV solution is officially stable for 24 hours at room temperature. Nicardipine must be stored out of the sight and reach of children. All single-dose containers require that any unused portion be discarded. Expired or unused nicardipine must be disposed of in accordance with local requirements, not via household waste or wastewater.